Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Your search returned 1000 results
-
Sep 1, 2008
Overall results demonstrated no statistically significant differences between PCI and CABG in rates of death or myocardial infarction (MI)
-
Aug 29, 2008
Boston Scientific obligation reduced from $250 to $19 million; Company to appeal remaining award
-
Aug 26, 2008
Company to present data from landmark SYNTAX clinical trial
-
Jul 21, 2008
"We were pleased with the quarter, especially with our expense management and working capital initiatives,” said CEO Jim Tobin.
-
Jul 2, 2008
Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms